June 24 – 28 2023

                                  
Rallybio presented the important results of their FNAIT Program ‘RLYB212’ at the ‘’International Society of Thrombosis and Haemostasis Congress – ISTH2023’’ held at the Palais des Congrès de Montréal, Quebec, Canada.  https://www.isth2023.org/

‘’Dose-Dependent Elimination of HPA-1a Platelets by Subcutaneous RLYB212, a Monoclonal Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia’’